<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">3 Biotech</span><span class="iso-abbrev" title="iso-abbrev">3 Biotech</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">3 Biotech</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">2190-572X</span><span class="issn-epub" tagx="issn" title="issn-epub">2190-5738</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">Springer International Publishing</span><span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Cham</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7885310">7885310</a></span><span class="publisher-id" title="publisher-id">2672</span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1007/s13205-021-02672-4">10.1007/s13205-021-02672-4</a></span><div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Short Reports</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
In vitro antimycobacterial studies of flavonols from <i>Bauhinia vahlii</i> Wight and Arn</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">http://orcid.org/0000-0002-9554-9092</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nguyen</span><span class="given-names" tagx="given-names" title="given-names">Thanh-Trung</span></span><span class="address" title="address"><span class="email" tagx="email" title="email">trungnt@duytan.edu.vn</span></span><a href="#Aff1">1</a><a href="#Aff2">2</a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">http://orcid.org/0000-0002-7229-8761</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ketha</span><span class="given-names" tagx="given-names" title="given-names">Alekhya</span></span><span class="address" title="address"><span class="email" tagx="email" title="email">kethaalekhya@gmail.com</span></span><a href="#Aff3">3</a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">http://orcid.org/0000-0003-2998-1415</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hieu</span><span class="given-names" tagx="given-names" title="given-names">Ho Viet</span></span><span class="address" title="address"><span class="email" tagx="email" title="email">hoviethieu@duytan.edu.vn</span></span><a href="#Aff4">4</a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">http://orcid.org/0000-0002-9376-1911</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tatipamula</span><span class="given-names" tagx="given-names" title="given-names">Vinay Bharadwaj</span></span><span class="address" title="address"><span class="email" tagx="email" title="email">vinaybharadwajtatipamula@duytan.edu.vn</span></span><a href="#Aff1">1</a><a href="#Aff2">2</a></span><span class="citation_author_institution" id="Aff1">[1], <div class="institution-wrap" title="institution-wrap"><span class="institution-id" title="institution-id">grid.444918.4</span><span class="institution-id" title="institution-id">0000 0004 1794 7022</span><span class="institution" title="institution">Institute of Research and Development, </span><span class="institution" title="institution">Duy Tan University, </span></div></span><span class="citation_author_institution" id="Aff2">[2], <div class="institution-wrap" title="institution-wrap"><span class="institution-id" title="institution-id">grid.444918.4</span><span class="institution-id" title="institution-id">0000 0004 1794 7022</span><span class="institution" title="institution">Faculty of Pharmacy, </span><span class="institution" title="institution">Duy Tan University, </span></div></span><span class="citation_author_institution" id="Aff3">[3], <div class="institution-wrap" title="institution-wrap"><span class="institution-id" title="institution-id">grid.411381.e</span><span class="institution-id" title="institution-id">0000 0001 0728 2694</span><span class="institution" title="institution">Pharmaceutical Chemistry Department, </span><span class="institution" title="institution">AU College of Pharmaceutical Sciences, Andhra University, </span></div></span><span class="citation_author_institution" id="Aff4">[4], <div class="institution-wrap" title="institution-wrap"><span class="institution-id" title="institution-id">grid.444918.4</span><span class="institution-id" title="institution-id">0000 0004 1794 7022</span><span class="institution" title="institution">Department of Medical Microbiology and Parasitology, Faculty of Medicine, </span><span class="institution" title="institution">Duy Tan University, </span></div></span></div><span class="pub-date-epub" title="pub-date-epub">epub: <span>2021-2-2</span></span><span class="pub-date-ppub" title="pub-date-ppub">ppub: <span>2021-3</span></span><span class="volume" tagx="volume" title="volume">11</span><span class="issue" tagx="issue" title="issue">3</span><span class="elocation-id" tagx="elocation-id" title="elocation-id">128</span><span class="history" title="history"><span class="received" title="received">received: 2020-11-27</span><span class="accepted" title="accepted">accepted: 2021-1-28</span></span><div class="permissions"><span class="copyright" title="copyright">(C) , </span></div> <div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <p id="Par1">Mycobacterial infections and fast-growing strains are increasing globally with 8 million new cases and 1.8 million fatalities per annum worldwide. The acid-fast bacterium, <i>Mycobacterium tuberculosis</i> (<i>M.t</i>), can spread diseases like tuberculosis (Tb) and weaken the immune system. In Ayurveda, the <i>Bauhinia</i> genus is most valued for the treatment of tuberculosis lymphadenitis. The objective of the present study is to identify anti-tubercular compounds from the under-investigated medicinal plant <i>B. vahlii</i> Wight and Arn. using bioassay guided isolation. The antimycobacterial activity was evaluated against non-virulent strains: <i>Mycobacterium tuberculosis</i> H37Ra (ATCC 25177) and <i>Mycobacterium bovis</i> BCG (ATCC 35743). Also, antibacterial and cytotoxicity activities were tested to identify the specificity of the isolated metabolites. Bioassay-guided isolation yielded three known flavonols, namely quercetin <b>(1)</b>, ombuin <b>(2)</b>, and kaempferol <b>(3),</b> from the methanolic extract of bark of <i>B. vahlii</i>. The results of antimycobacterial activity tests revealed that <b>2</b> showed much better mycobactericidal activity than 1 and 3 under ex vivo condition with minimum inhibitory concentration (MIC) values ranged from 0.05â€‰Â±â€‰0.01 to 0.26â€‰Â±â€‰0.01Â nM, and half-maximal inhibitory concentration (IC<sub>50</sub>) values ranged from 2.85â€‰Â±â€‰0.14 to 7.21â€‰Â±â€‰1.09Â nM against dormant and active forms, respectively. Also, compound <b>2</b> showed higher resistance with MIC valuesâ€‰&amp;gt;â€‰100Â Î¼g/mL against both Gram-positive and Gram-negative bacteria and the least cytotoxicity up to 100Â Î¼g/mL concentration against the tested series of cancer cell lines. The results revealed the Ayurvedic use of extracts of the <i>Bauhinia</i> genus for treating tuberculosis, and the key bioactive compounds were found to be flavonols <b>(1â€"3)</b>. The present work provides the first evidence for the presence of antimycobacterial compounds in <i>B. vahlii</i>.</p> <div class="supplementaryinformation" title="sec"> <div class="title" tagx="title" title="title">
Supplementary Information</div> <p>The online version contains supplementary material available at 10.1007/s13205-021-02672-4.</p> </div> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Keywords</div> <div class="kwd" title="kwd">
Antibacterial activity</div> <div class="kwd" title="kwd">
Antimycobacterial activity</div> <div class="kwd" title="kwd"><i>B. vahlii</i></div> <div class="kwd" title="kwd">
Cytotoxicity</div> <div class="kwd" title="kwd">
Flavonols</div> </div> <div class="custom-meta-group" title="custom-meta-group"> <meta name="issue-copyright-statement" value="Â© King Abdulaziz City for Science and Technology 2021" /> </div> </div> </div> <div class="body" title="body"> <div class="introduction" title="sec"> <div class="title" tagx="title" title="title">
Introduction</div> <p id="Par2">Acid-fast bacilli, <i>Mycobacterium tuberculosis</i> (<i>M.t</i>), is a huge threat to human health. The acid-fast bacterium can spread diseases like tuberculosis (Tb) and weakens the immune system (Behr et al. <a href="#CR2">1999</a>). However, depending on the illness, Tb requires drug therapy of antibiotics (commonly, rifampicin and isoniazid) for at least 1â€"6 months (Global Tuberculosis Report <a href="#CR9">2020</a>), and the side effects of many anti-Tb drugs are severe. Usually, the treatment also causes the occurrence of extremely drug-resistant and multidrug-resistant strains of <i>M.t</i> (Gagneux <a href="#CR7">2006</a>; Paidi et al. <a href="#CR10">2017</a>). According to the World Health Organization (WHO) Global Tb Programme Report <a href="#CR9">2020</a>, the COVID-19 pandemic situation has had a negatively impacted on care services and detection of Tb cases globally and the mortality rate of Tb patients have also increased (Glaziou <a href="#CR8">2020</a>). Therefore, Tb has been declared a global emergency by the WHO (Glaziou <a href="#CR8">2020</a>; Rakotonirina et al. <a href="#CR12">2009</a>). Hence, in search of alternative antimycobacterial agents, we concentrated our efforts toward screening natural sources like <i>B. vahlii</i> Wight and Arn. (Family: Fabaceae), against <i>M.t</i> strains and isolating the marker compounds.</p> <p id="Par3">In Ayurveda, the bark, flowers, and roots of genus <i>Bauhinia</i> are most valued for the treatment of scrofula, tuberculosis lymphadenitis, worm infestation, and wounds. The broad spectrum of biological activities of this genus is mainly due to the presence of flavonols, flavanones, bibenzyls, triterpenes, flavonol-glycosides, saponins, and phenanthraquinones. The antimycobacterial activity of some flavanones and bibenzyls from <i>Bauhinia purpurea</i> has already been reported (Boonphong et al. <a href="#CR3">2007</a>). With this background, we have presented results of bioassay-guided isolation and characterization of flavonols from <i>B. vahlii</i> and their antimycobacterial activity in both in vitro and ex vivo conditions.</p> </div> <div class="materialsandmethods" title="sec"> <div class="title" tagx="title" title="title">
Materials and methods</div> <div class="plantmaterial" title="sec"> <div class="title" tagx="title" title="title">
Plant material</div> <p id="Par4">Bark of <i>B. vahlii</i> Wight and Arn. was collected at Seshachalam hills (Tirupati), India, in Mar 2019, and a voucher specimen (DB-SVU-2019-3478) was deposited at the Department of Botany, Sri Venkateswara University, Tirupati, India.</p> </div> <div class="extractionandbioassay-guidedisolation" title="sec"> <div class="title" tagx="title" title="title">
Extraction and bioassay-guided isolation</div> <p id="Par5">Dried bark (about 250Â g) was powdered and extracted by the maceration method (Tatipamula et al. <a href="#CR19">2020</a>) using 90% methanol (3â€‰Ã—â€‰500Â mLâ€‰Ã—â€‰7Â days) at 25Â â"ƒ. All the extract was combined and evaporated under low pressure using rotavapor (Shimadzu Rotation evaporator QR 2005-S, Japan) to obtain crude methanol extract of bark of <i>B. vahlii</i> (<b>ME</b>, 4.5Â g) as a dark black solid. <b>ME</b> was subsequently screened and found to be effective against <i>M. tuberculosis</i> (<i>M.t</i>) H37Ra (ATCC 25177) (Table <a href="#Tab1">1</a>). <div class="table-wrap_UNKNOWN" id="Tab1"><span class="label" tagx="label" title="label">Table 1</span> </div></p><p>Yield and primary screening of anti-tubercular activity of methanol extract <b>(ME)</b>, fractions <b>(F1â€"7),</b> and compounds <b>(1â€"3)</b> from <i>B. vahlii</i> Wight and Arn</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th align="left" rowspan="2">Sample</th> <th align="left" rowspan="2">Yield (mg)</th> <th align="left" colspan="3">% inhibition of <i>M.t</i> H37Ra (ATCC 25177)<sup>a</sup></th> </tr> <tr> <th align="left">10Â Î¼g/mL</th> <th align="left">30Â Î¼g/mL</th> <th align="left">100Â Î¼g/mL</th> </tr> </thead> <tbody> <tr> <td align="left">ME</td> <td align="left">4000</td> <td char="Â±" align="char">48.63â€‰Â±â€‰1.20</td> <td char="Â±" align="char">68.58â€‰Â±â€‰1.82</td> <td char="Â±" align="char">81.71â€‰Â±â€‰3.10</td> </tr> <tr> <td align="left">F1</td> <td align="left">800</td> <td char="Â±" align="char">2.19â€‰Â±â€‰0.30</td> <td char="Â±" align="char">2.73â€‰Â±â€‰0.57</td> <td char="Â±" align="char">4.80â€‰Â±â€‰0.28</td> </tr> <tr> <td align="left">F2</td> <td align="left">450</td> <td char="Â±" align="char">0.69â€‰Â±â€‰0.10</td> <td char="Â±" align="char">1.31â€‰Â±â€‰0.12</td> <td char="Â±" align="char">2.01â€‰Â±â€‰0.79</td> </tr> <tr> <td align="left">F3</td> <td align="left">620</td> <td char="Â±" align="char">9.86â€‰Â±â€‰1.02</td> <td char="Â±" align="char">14.77â€‰Â±â€‰2.60</td> <td char="Â±" align="char">28.49â€‰Â±â€‰0.70</td> </tr> <tr> <td align="left">F4</td> <td align="left">250</td> <td char="Â±" align="char">65.07â€‰Â±â€‰1.57</td> <td char="Â±" align="char">76.84â€‰Â±â€‰1.56</td> <td char="Â±" align="char">90.01â€‰Â±â€‰3.06</td> </tr> <tr> <td align="left">F5</td> <td align="left">310</td> <td char="Â±" align="char">16.69â€‰Â±â€‰0.79</td> <td char="Â±" align="char">20.69â€‰Â±â€‰1.91</td> <td char="Â±" align="char">28.49â€‰Â±â€‰0.70</td> </tr> <tr> <td align="left">F6</td> <td align="left">200</td> <td char="Â±" align="char">56.69â€‰Â±â€‰2.46</td> <td char="Â±" align="char">68.14â€‰Â±â€‰1.59</td> <td char="Â±" align="char">90.96â€‰Â±â€‰3.72</td> </tr> <tr> <td align="left">F7</td> <td align="left">550</td> <td char="Â±" align="char">18.85â€‰Â±â€‰2.81</td> <td char="Â±" align="char">22.13â€‰Â±â€‰2.19</td> <td char="Â±" align="char">34.21â€‰Â±â€‰4.18</td> </tr> <tr> <td align="left">1</td> <td align="left">80</td> <td char="Â±" align="char">66.65â€‰Â±â€‰6.90</td> <td char="Â±" align="char">80.53â€‰Â±â€‰5.88</td> <td char="Â±" align="char">89.19â€‰Â±â€‰2.20</td> </tr> <tr> <td align="left">2</td> <td align="left">60</td> <td char="Â±" align="char">71.22â€‰Â±â€‰5.19</td> <td char="Â±" align="char">82.19â€‰Â±â€‰7.23</td> <td char="Â±" align="char">93.88â€‰Â±â€‰3.90</td> </tr> <tr> <td align="left">3</td> <td align="left">50</td> <td char="Â±" align="char">23.85â€‰Â±â€‰5.62</td> <td char="Â±" align="char">29.29â€‰Â±â€‰4.28</td> <td char="Â±" align="char">44.41â€‰Â±â€‰2.67</td> </tr> <tr> <td align="left">Rifampicin</td> <td align="left">NA</td> <td char="Â±" align="char">71.02â€‰Â±â€‰0.24</td> <td char="Â±" align="char">92.26â€‰Â±â€‰2.02</td> <td char="Â±" align="char">96.01â€‰Â±â€‰0.64</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <p><sup>a</sup>Meanâ€‰Â±â€‰SD (<i>n</i>â€‰=â€‰3); <i>M.t</i>: <i>Mycobacterium tuberculosis</i>, <i>NA</i> not applicable</p> </div>  <p /> <p id="Par6">About 3.0Â g of <b>ME</b> was subjected to column chromatography (sintered disc column, 600Â mmâ€‰Ã—â€‰45Â mm; Product code: 6101067, Borosil, India) over silica gel (230â€"400 mesh, CAS No.: 112926-00-8, Merck) by employing a mobile phase hexaneâ€"ethyl acetate gradient (0â€"100%) yielding seven fractions <b>(F1-7)</b>. These fractions were concentrated in a vacuum and screened in an antimycobacterial assay using <i>M.t</i> H37Ra (ATCC 25177) strain (Singh et al. <a href="#CR15">2015</a>; Paidi et al. <a href="#CR11">2018</a>).</p> <p id="Par7">From these results, it was evident that two fractions (<b>F4</b> and <b>F6</b>) exhibited prominent inhibitory action against <i>M.t</i> H37Ra, suggesting further purification to identify marker compounds. <b>F4</b> (250Â mg) after purification by repeated chromatography (sintered disc column, 300Â mmâ€‰Ã—â€‰18Â mm; Product code: 6101062, Borosil, India) and preparative thin-layer chromatography (TLC) (pre-coated glass silica plates, TLC-Silica gel 60 GF<sub>254</sub>, CAS: 7631-86-9, Merck, Germany) yielded <b>1</b> (80Â mg). Similarly, <b>F6</b> (200Â mg) after purification by repeated chromatography (sintered disc column, 300Â mmâ€‰Ã—â€‰18Â mm; Product code: 6101062, Borosil, India) using hexaneâ€"ethyl acetate gradient (0â€"100%) and preparative TLC (TLC-Silica gel 60 GF<sub>254</sub>, CAS: 7631-86-9, Merck, Germany) yielded compounds <b>2</b> (60Â mg) and <b>3</b> (50Â mg). Furthermore, proton (1H)-nuclear magnetic resonance (NMR) and Carbon-13 (13C)-NMR (Bruker Avance 400 Spectrometer, Germany), Mass (LC/MS Triple Quad Portfolio, Agilent, China) spectral analyses, melting point determination (M-560/565 Melting Point Apparatus, Buchi, Switzerland), and elemental analyses (2400 CHNS Organic Elemental Analyzer, PerkinElmer, USA) were applied for the structure elucidation of isolated compounds. The measurements of Mass and NMR spectrophotometers were made using Robust mass spectrometry application software (Sturm et al. <a href="#CR16">2008</a>) and Brukerâ€™s topspin software (Baldisseri and Biospin <a href="#CR1">2018</a>), respectively.</p> </div> <div class="invitroandexvivoantimycobacterialassay" title="sec"> <div class="title" tagx="title" title="title">
In vitro and ex vivo antimycobacterial assay</div> <p id="Par8">In the current study, antimycobacterial activity was evaluated against a non-virulent strain of <i>M.t</i> in a liquid medium in triplicate. Standard cultures of <i>M.t</i> H37Ra (ATCC 25177) and <i>Mycobacterium bovis</i> BCG (ATCC 35743) were procured from the American Type Culture Collection (ATCC, Manassas, Virginia). <i>M.t</i> and <i>M. bovis</i> were grown and maintained as per standard protocols (Singh et al. <a href="#CR15">2015</a>; Paidi et al. <a href="#CR11">2018</a>). The bark extract (<b>ME</b>), fractions <b>(F1-7)</b>, and isolated compounds <b>(1â€"3)</b> were screened for <i>M.t</i> inhibitory activity at 10, 30, and 100Â Î¼g/mL concentrations using 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) reduction menadione assay (XRMA) at 470Â nm (Singh et al. <a href="#CR14">2011</a>). The inhibition of <i>M. bovis</i> was estimated using nitrate reductase (NR) assay at 540Â nm (Singh et al. <a href="#CR15">2015</a>). Through doseâ€"response curves, minimum inhibitory concentration (MIC), and half-maximal inhibitory concentration (IC<sub>50</sub>) values were calculated against mycobacteria strains. Rifampicin was taken as a standard.</p> </div> <div class="invitroantibacterialassay" title="sec"> <div class="title" tagx="title" title="title">
In vitro antibacterial assay</div> <p id="Par9">To determine specificity, compounds <b>1â€"3</b> at 0.1, 0.3, 1, 3, 10, 30, and 100Â Î¼g/mL concentrations were tested against bacteria strains [two Gram-positive: <i>S. aureus</i> (ATCC25923), <i>B. subtilis</i> (ATCC21332), and two Gram-negative: <i>S. typhi</i> (ATCC1408), <i>E. coli</i> (ATCC25922)] in triplicate. In a 96-well microtitre plate, 1%v/v LB broth and the optical density (OD)-adjusted culture (OD620â€‰=â€‰1) were inoculated (Dzoyem et al. <a href="#CR6">2013</a>; Shetty et al. <a href="#CR13">2014</a>). Then, isolated compounds <b>(1â€"3)</b> of 2.5Â Î¼L and culture (247.5Â Î¼L) were added and incubated at 37Â Â°C for 18Â h. Wells for sterility control and growth were also included, and streptomycin was used as a standard. The absorbance was measured at 620Â nm. Through doseâ€"response curves, MIC and IC<sub>50</sub> values were calculated against strains.</p> </div> <div class="cytotoxicityassay" title="sec"> <div class="title" tagx="title" title="title">
Cytotoxicity assay</div> <p id="Par10">The breast (MDA-MB-231), cervical (HT-3), and ovarian (SKOV3) cancer cell lines were procured from the National Centre for Cell Science, Pune, India, and maintained according to the standard established procedures (Chitturi et al. <a href="#CR4">2015</a>, <a href="#CR5">2016</a>). In vitro potential effects of compounds (<b>1â€"3</b>) on cell death were investigated through 3-(4, 5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) assay in triplicate (Tatipamula and Vedula <a href="#CR17">2018</a>; Tatipamula et al. <a href="#CR18">2019</a>). Through doseâ€"response curves, IC<sub>50</sub> values were calculated against cancer cell lines.</p> </div> </div> <div class="resultsanddiscussion" title="sec"> <div class="title" tagx="title" title="title">
Results and discussion</div> <p id="Par11">To identify the bioactive antimycobacterial compounds from <b>ME</b>, it was fractionated using column chromatography, into seven fractions, namely <b>F1â€"7</b>. They were then screened for inhibitory action against <i>M.t</i> H37Ra. In preliminary screening,â€‰~â€‰90% inhibition was observed for only <b>ME, F4,</b> and <b>F6</b>; others showedâ€‰&amp;gt;â€‰28% inhibition against <i>M.t</i> H37Ra strain (Table <a href="#Tab1">1</a>). Further purification of <b>F4</b> and <b>F6</b> yielded compounds <b>1â€"3</b>. By elemental and spectral analysis, these compounds were identified as quercetin <b>(1)</b>, ombuin <b>(2)</b>, and kaempferol <b>(3)</b> (Fig.Â <a href="#Fig1">1</a>). </p><div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 1</span></a></div>   <p>Chemical representation of isolated flavonols <b>(1â€"3)</b> from <i>B. vahlii</i></p>   </div> <p /> <p id="Par12">Compounds <b>1</b> and <b>2</b> obtained from <b>F4</b> and <b>F6</b>, respectively, showed profound mycobactericidal strength, inhibitingâ€‰~â€‰90% of mycobacterial growth. Depending upon primary screening, active compounds <b>1</b> and <b>2</b> at a concentration range of 0.03â€"30Â Î¼g/mL were further evaluated to determine their IC<sub>50</sub> and MIC values against dormant (12Â daysâ€™ incubation) and active (8Â dayâ€™s incubation) forms of <i>M.t</i> in both in vitro (<i>M.t</i> and <i>M. bovis</i> BCG), and ex vivo (<i>M.t</i>) conditions using the XRMA and NR assays. The results revealed the strong antimycobacterial activity of compounds <b>1</b> and <b>2</b> (Fig.Â <a href="#Fig2">2</a>). </p><div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 2</span></a></div>   <p>Half-maximal inhibitory concentration (IC<sub>50</sub>) values of compounds <b>1</b> and <b>2</b> against <b>a</b> in vitro<i> M. tuberculosis</i> H37Ra; <b>b</b> in vitro<i> M. bovis</i> BCG; <b>c</b> ex vivo<i> M. tuberculosis</i> H37Ra<i>.</i> Minimum inhibitory concentration (MIC) values of compounds <b>1</b> and <b>2</b> against <b>d</b> in vitro<i> M. tuberculosis</i> H37Ra; <b>e</b> in vitro<i> M. bovis</i> BCG; <b>F.</b> ex vivo<i> M. tuberculosis</i> H37Ra. *Meanâ€‰Â±â€‰SD (<i>n</i>â€‰=â€‰3); Statistical analysis determined by <i>t</i> test where ***<i>p</i> &amp;lt; 0.0001 is statistically significant compared to rifampicin. IC<sub>50</sub> and MIC values are the lowest concentration of samples exhibiting percentage growth inhibition of 50% andâ€‰â‰¥â€‰90%, respectively, relative to the growth control</p>   </div> <p /> <p id="Par13">Compound <b>1</b> was found to be extremely effective in inhibiting both active and dormant forms of <i>M. bovis</i> BCG (in vitro), and <i>M.t</i> (ex vivo) with MIC values ranged from 3.21â€‰Â±â€‰0.09 to 10.26â€‰Â±â€‰0.73Â nM (Fig.Â <a href="#Fig2">2</a>e, f), and IC<sub>50</sub> values ranged from 0.13â€‰Â±â€‰0.01 to 4.90â€‰Â±â€‰0.60Â nM (Fig.Â <a href="#Fig2">2</a>b, c). A higher concentration of compound <b>1</b> was required for complete inhibition of both active and dormant forms of <i>M.t</i> (in vitro) (Fig.Â <a href="#Fig2">2</a>a, d). Alternatively, compound <b>2</b> showed much better mycobactericidal activity under ex vivo conditions with MIC values of 0.05â€‰Â±â€‰0.01 and 0.26â€‰Â±â€‰0.01Â nM (Fig.Â <a href="#Fig2">2</a>f), and IC<sub>50</sub> values of 2.85â€‰Â±â€‰0.14 and 7.21â€‰Â±â€‰1.09Â nM against dormant and active forms, respectively (Fig.Â <a href="#Fig2">2</a>c). Compound <b>2</b> exhibited the least activity against the dormant stage of <i>M.t</i> (in vitro) with MIC valueâ€‰~â€‰300Â nM (Fig.Â <a href="#Fig2">2</a>d) and the IC<sub>50</sub> value of 15.86â€‰Â±â€‰1.10Â nM (Fig.Â <a href="#Fig2">2</a>a). However, the IC<sub>50</sub> value of compound <b>2</b> in the dormant stage of <i>M.t</i> (in vitro) was detected to be lesser than in its active stage. Taken together, the overall antimycobacterial activity exhibited by compounds <b>1</b> and <b>2</b> was significant, although they hold inferior potencies compared to rifampicin.</p> <p id="Par14">To check the antimicrobial specificity of compounds <b>1â€"3,</b> we tested them against two Gram-negative bacteria (<i>S. typhi</i> and <i>E. coli</i>) and two Gram-positive bacteria (<i>S. aureus</i> and <i>B. subtilis</i>). Compounds <b>2</b> and <b>3</b> showed higher resistance with MIC valuesâ€‰&amp;gt;â€‰100Â Î¼g/mL against both Gram-positive and Gram-negative bacteria (Table <a href="#Tab2">2</a>). Moreover, the MIC values of compound <b>1</b> against tested bacterial strains ranged from 69.15â€‰Â±â€‰1.30 to 151.20â€‰Â±â€‰5.10Â nM (Table <a href="#Tab2">2</a>). This indicates that compound <b>2</b> isolated from <b>ME</b>, has greater specificity toward mycobacteria than <b>1</b>. <div class="table-wrap_UNKNOWN" id="Tab2"><span class="label" tagx="label" title="label">Table 2</span> </div></p><p>In vitro antibacterial activity of compounds <b>(1â€"3)</b> isolated from methanolic extract of bark of <i>B. vahlii</i></p>  <table frame="hsides" rules="groups"> <thead> <tr> <th align="left" rowspan="2">Sample</th> <th align="left" colspan="2"><i>S. aurues</i><sup>a</sup></th> <th align="left" colspan="2"><i>B. subtilis</i><sup>a</sup></th> <th align="left" colspan="2"><i>S. typhi</i><sup>a</sup></th> <th align="left" colspan="2"><i>E. coli</i><sup>a</sup></th> </tr> <tr> <th align="left">IC<sub>50</sub></th> <th align="left">MIC</th> <th align="left">IC<sub>50</sub></th> <th align="left">MIC</th> <th align="left">IC<sub>50</sub></th> <th align="left">MIC</th> <th align="left">IC<sub>50</sub></th> <th align="left">MIC</th> </tr> </thead> <tbody> <tr> <td align="left">1</td> <td align="left">41.03â€‰Â±â€‰2.27</td> <td align="left">69.15â€‰Â±â€‰1.30</td> <td align="left">25.81â€‰Â±â€‰2.18</td> <td align="left">131.39â€‰Â±â€‰8.00</td> <td align="left">80.13â€‰Â±â€‰4.17</td> <td align="left">143.73â€‰Â±â€‰7.26</td> <td align="left">117.22â€‰Â±â€‰4.35</td> <td align="left">151.20â€‰Â±â€‰5.10</td> </tr> <tr> <td align="left">2</td> <td align="left">287.63â€‰Â±â€‰6.36</td> <td align="left">290.65â€‰Â±â€‰10.34</td> <td align="left">299.74â€‰Â±â€‰9.25</td> <td align="left">â€"</td> <td align="left">207.61â€‰Â±â€‰15.38</td> <td align="left">â€"</td> <td align="left">223.29â€‰Â±â€‰16.70</td> <td align="left">267.73â€‰Â±â€‰9.26</td> </tr> <tr> <td align="left">3</td> <td align="left">â€"</td> <td align="left">â€"</td> <td align="left">â€"</td> <td align="left">â€"</td> <td align="left">â€"</td> <td align="left">â€"</td> <td align="left">â€"</td> <td align="left">â€"</td> </tr> <tr> <td align="left">Streptomycin</td> <td align="left">0.34â€‰Â±â€‰0.05</td> <td align="left">2.86â€‰Â±â€‰0.13</td> <td align="left">16.86â€‰Â±â€‰1.13</td> <td align="left">29.54â€‰Â±â€‰2.45</td> <td align="left">8.10â€‰Â±â€‰0.89</td> <td align="left">12.48â€‰Â±â€‰1.00</td> <td align="left">1.17â€‰Â±â€‰0.13</td> <td align="left">4.18â€‰Â±â€‰0.30</td> </tr> <tr> <td align="left">Rifampicin</td> <td align="left">19.44â€‰Â±â€‰1.04</td> <td align="left">36.45â€‰Â±â€‰2.00</td> <td align="left">0.30â€‰Â±â€‰0.03</td> <td align="left">1.64â€‰Â±â€‰0.35</td> <td align="left">0.12â€‰Â±â€‰0.03</td> <td align="left">0.60â€‰Â±â€‰0.06</td> <td align="left">0.81â€‰Â±â€‰0.09</td> <td align="left">1.97â€‰Â±â€‰0.22</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <p><sup>a</sup>Values are expressed as nM (meanâ€‰Â±â€‰SD, <i>n</i>â€‰=â€‰3); â€œ-â€� indicate not active up to 100Â Î¼g/mL concentration; half-maximal inhibitory concentration (IC<sub>50</sub>) and minimum inhibitory concentration (MIC) values are lowest concentration of samples exhibiting percentage growth inhibition of 50% andâ€‰â‰¥â€‰90%, respectively, relative to the growth control</p> </div>  <p /> <p id="Par15">Furthermore, compounds <b>1â€"3</b> were tested against MDA-MB-231, HT-3, and SKOV3 human cancer cell lines for their cytotoxicity. Fig. S1 represents the percentage of cytotoxicity and IC<sub>50</sub> values obtained against MDA-MB-231, HT-3, and SKOV3 cancer cell lines through MTT cell proliferation assay. At 100Â Âµg/mL concentration, compounds <b>1</b> and <b>3</b> exhibitedâ€‰~â€‰44 andâ€‰~â€‰53% inhibition, respectively, of MDA-MB-231 and HT-3, suggesting the biocompatible nature of these compounds. Compound <b>2</b> showed the least cytotoxicity up to 100Â Î¼g/mL concentration against the tested series of cancer cell lines. The tested concentration was nearly ten times greater than the detected MIC values for <i>M.t</i> in ex vivo conditions. Overall, the cytotoxicity results suggest the biocompatible nature of compounds <b>1</b>â€"<b>3</b>.</p> <p id="Par16">To conclude, the present work provides the first evidence for the presence of antimycobacterial compounds in <i>B. vahlii</i>. Hence, we report the bioassay-guided isolation of marker compounds <b>1â€"2</b> from the bark of <i>B. vahlii,</i> possessing significant inhibitory actions against non-virulent <i>M.t</i> strains (both in vitro and ex vivo). This study supports the prediction of predominant binding mode(s) of compounds <b>1</b> and <b>2</b> within <i>M.t</i> proteins (like DprE1) that help to recognize the ligandâ€"protein interactions and establish a structural basis for inhibition of <i>M.t</i> strains.</p> </div> <div class="supplementary-material" title="supplementary-material"> <div class="title" tagx="title" title="title">
Supplementary Information</div> <div class="sec" title="sec"> <p>Below is the link to the electronic supplementary material. </p><div class="local-data" title="local-data"> <div class="media" title="media"><a href="13205_2021_2672_MOESM1_ESM.doc">LINK</a> <p>Supplementary file1 (DOC 2211 KB)</p>  </div> </div> <p /> </div> </div> </div> <div class="back" title="back"> <div class="ack" title="ack"> <div class="title" tagx="title" title="title">
Acknowledgements</div> <p>The authors would like to thank AU College of Pharmaceutical Sciences, Andhra University, Visakhapatnam for providing the necessary facilities to complete the present work. The authors would also like to thank Adam F. Johnson (Institute of Research and Development, Duy Tan University, Danang, Vietnam) for the critical reading of the manuscript.</p> </div> <div class="title" tagx="title" title="title">
Authorâ€™s contribution</div> <p>T-TN proposed and monitored the biological assays and co-wrote the manuscript. AK and HVH helped with isolation and biological evaluations. VBT conceived the study, analyzed the data, and wrote the manuscript. All authors have read and approved the manuscript.</p> <div class="title" tagx="title" title="title">
Compliance with ethical standards</div> <div class="title" tagx="title" title="title">
Conflict of interest</div> <p id="Par17">The authors declare that they have no conflict of interest in the publication.</p> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="CR1" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">Baldisseri DM, Biospin B (2018) Practical aspects of fragment-based screening experiments in TopSpin. Brucker. <a href="https://www.bruker.com/fileadmin/user_upload/8-PDF-Docs/MagneticResonance/NMR/brochures/FBS_appsnote_T169075.pdf">https://www.bruker.com/fileadmin/user_upload/8-PDF-Docs/MagneticResonance/NMR/brochures/FBS_appsnote_T169075.pdf</a>. Accessed on 28 Dec 2020</span></li> <li tag="ref"><a name="CR2" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Behr</span><span class="given-names" tagx="given-names" title="given-names">MA</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Warren</span><span class="given-names" tagx="given-names" title="given-names">SA</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Salamon</span><span class="given-names" tagx="given-names" title="given-names">H</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli</span><span class="source" tagx="source" title="source">Lancet</span><span class="year" tagx="year" title="year">1999</span><span class="volume" tagx="volume" title="volume">353</span><span class="fpage" tagx="fpage" title="fpage">44</span><span class="lpage" tagx="lpage" title="lpage">449</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/S0140-6736(98)03406-0">10.1016/S0140-6736(98)03406-0</a></span></span></li> <li tag="ref"><a name="CR3" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Boonphong</span><span class="given-names" tagx="given-names" title="given-names">S</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Puangsombat</span><span class="given-names" tagx="given-names" title="given-names">P</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Baramee</span><span class="given-names" tagx="given-names" title="given-names">A</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Bioactive compounds from <i>Bauhinia purpurea</i> possessing antimalarial, antimycobacterial, antifungal, anti-inflammatory, and cytotoxic activities</span><span class="source" tagx="source" title="source">J Nat Prod</span><span class="year" tagx="year" title="year">2007</span><span class="volume" tagx="volume" title="volume">70</span><span class="fpage" tagx="fpage" title="fpage">795</span><span class="lpage" tagx="lpage" title="lpage">801</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/np070010e">10.1021/np070010e</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17480099">17480099</a></span></span></li> <li tag="ref"><a name="CR4" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chitturi</span><span class="given-names" tagx="given-names" title="given-names">BR</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chanti</span><span class="given-names" tagx="given-names" title="given-names">DB</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tatipamula</span><span class="given-names" tagx="given-names" title="given-names">VB</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Isolation, structural assignment and synthesis of (S, E)-2-methyloctyl 3-(4-methoxyphenyl) propenoate from the marine soft coral Sarcophyton ehrenbergi</span><span class="source" tagx="source" title="source">Nat Prod Res</span><span class="year" tagx="year" title="year">2015</span><span class="volume" tagx="volume" title="volume">29</span><span class="fpage" tagx="fpage" title="fpage">70</span><span class="lpage" tagx="lpage" title="lpage">76</span><span class="pub-id"><a href="https://dx.doi.org/10.1080/14786419.2014.958742">10.1080/14786419.2014.958742</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25229804">25229804</a></span></span></li> <li tag="ref"><a name="CR5" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chitturi</span><span class="given-names" tagx="given-names" title="given-names">BR</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tatipamula</span><span class="given-names" tagx="given-names" title="given-names">VB</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dokuburra</span><span class="given-names" tagx="given-names" title="given-names">CB</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Pambanolides A-C from the South Indian soft coral Sinularia inelegans</span><span class="source" tagx="source" title="source">Tetrahedron</span><span class="year" tagx="year" title="year">2016</span><span class="volume" tagx="volume" title="volume">72</span><span class="fpage" tagx="fpage" title="fpage">1933</span><span class="lpage" tagx="lpage" title="lpage">1940</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.tet.2016.02.056">10.1016/j.tet.2016.02.056</a></span></span></li> <li tag="ref"><a name="CR6" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dzoyem</span><span class="given-names" tagx="given-names" title="given-names">JP</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guru</span><span class="given-names" tagx="given-names" title="given-names">SK</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pieme</span><span class="given-names" tagx="given-names" title="given-names">CA</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Cytotoxic and antimicrobial activity of selected Cameroonian edible plants</span><span class="source" tagx="source" title="source">BMC Complement Altern Med</span><span class="year" tagx="year" title="year">2013</span><span class="volume" tagx="volume" title="volume">13</span><span class="fpage" tagx="fpage" title="fpage">78</span><span class="pub-id"><a href="https://dx.doi.org/10.1186/1472-6882-13-78">10.1186/1472-6882-13-78</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23565827">23565827</a></span></span></li> <li tag="ref"><a name="CR7" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gagneux</span><span class="given-names" tagx="given-names" title="given-names">S</span></span></span><span class="mixed-article-title" title="mixed-article-title">The competitive cost of antibiotic resistance in Mycobacterium tuberculosis</span><span class="source" tagx="source" title="source">Science</span><span class="year" tagx="year" title="year">2006</span><span class="volume" tagx="volume" title="volume">312</span><span class="fpage" tagx="fpage" title="fpage">1944</span><span class="lpage" tagx="lpage" title="lpage">1946</span><span class="pub-id"><a href="https://dx.doi.org/10.1126/science.1124410">10.1126/science.1124410</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16809538">16809538</a></span></span></li> <li tag="ref"><a name="CR8" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">Glaziou P (2020) Predicted impact of the COVID-19 pandemic on global tuberculosis deaths in 2020. medRxiv. 10.1101/2020.04.28.20079582</span></li> <li tag="ref"><a name="CR9" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">Global Tuberculosis Report (2020) Tuberculosis. World Health Organization Newsletters. <a href="https://www.who.int/health-topics/tuberculosis#tab=tab_3">https://www.who.int/health-topics/tuberculosis#tab=tab_3</a>. Accessed on 26 Dec 2020</span></li> <li tag="ref"><a name="CR10" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Paidi</span><span class="given-names" tagx="given-names" title="given-names">K</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tatipamula</span><span class="given-names" tagx="given-names" title="given-names">V</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kolli</span><span class="given-names" tagx="given-names" title="given-names">M</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pedakotla</span><span class="given-names" tagx="given-names" title="given-names">V</span></span></span><span class="mixed-article-title" title="mixed-article-title">Benzohydrazide incorporated imidazo [1,2-b] pyridazine: synthesis, characterization and in vitro anti-tubercular activity</span><span class="source" tagx="source" title="source">Int J Chem Sci</span><span class="year" tagx="year" title="year">2017</span><span class="volume" tagx="volume" title="volume">15</span><span class="fpage" tagx="fpage" title="fpage">172</span></span></li> <li tag="ref"><a name="CR11" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Paidi</span><span class="given-names" tagx="given-names" title="given-names">KR</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tatipamula</span><span class="given-names" tagx="given-names" title="given-names">VB</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kolli</span><span class="given-names" tagx="given-names" title="given-names">MK</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis of imidazo[1,2-b] pyridazine comprised piperazine, morpholine derivatives as potent antimycobacterial agents with in vivo locomotor activity</span><span class="source" tagx="source" title="source">Anti Infect Agent</span><span class="year" tagx="year" title="year">2018</span><span class="volume" tagx="volume" title="volume">15</span><span class="fpage" tagx="fpage" title="fpage">131</span><span class="lpage" tagx="lpage" title="lpage">139</span><span class="pub-id"><a href="https://dx.doi.org/10.2174/2211352515666170821155217">10.2174/2211352515666170821155217</a></span></span></li> <li tag="ref"><a name="CR12" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rakotonirina</span><span class="given-names" tagx="given-names" title="given-names">E-CJ</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ravaoarisoa</span><span class="given-names" tagx="given-names" title="given-names">L</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Randriatsarafara</span><span class="given-names" tagx="given-names" title="given-names">FM</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Facteurs associÃ©s Ã lâ€™abandon du traitement anti-tuberculeux dans la ville dâ€™Antananarivo</span><span class="source" tagx="source" title="source">Madagascar Sante Publique (Paris)</span><span class="year" tagx="year" title="year">2009</span><span class="volume" tagx="volume" title="volume">21</span><span class="fpage" tagx="fpage" title="fpage">139</span><span class="pub-id"><a href="https://dx.doi.org/10.3917/spub.092.0139">10.3917/spub.092.0139</a></span></span></li> <li tag="ref"><a name="CR13" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shetty</span><span class="given-names" tagx="given-names" title="given-names">PR</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Buddana</span><span class="given-names" tagx="given-names" title="given-names">SK</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tatipamula</span><span class="given-names" tagx="given-names" title="given-names">VB</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Production of polypeptide antibiotic from Streptomyces parvulus and its antibacterial activity</span><span class="source" tagx="source" title="source">Brazilian J Microbiol</span><span class="year" tagx="year" title="year">2014</span><span class="volume" tagx="volume" title="volume">45</span><span class="fpage" tagx="fpage" title="fpage">303</span><span class="lpage" tagx="lpage" title="lpage">312</span><span class="pub-id"><a href="https://dx.doi.org/10.1590/S1517-83822014005000022">10.1590/S1517-83822014005000022</a></span></span></li> <li tag="ref"><a name="CR14" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Singh</span><span class="given-names" tagx="given-names" title="given-names">U</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Akhtar</span><span class="given-names" tagx="given-names" title="given-names">S</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mishra</span><span class="given-names" tagx="given-names" title="given-names">A</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sarkar</span><span class="given-names" tagx="given-names" title="given-names">D</span></span></span><span class="mixed-article-title" title="mixed-article-title">A novel screening method based on menadione mediated rapid reduction of tetrazolium salt for testing of anti-mycobacterial agents</span><span class="source" tagx="source" title="source">J Microbiol Method</span><span class="year" tagx="year" title="year">2011</span><span class="volume" tagx="volume" title="volume">84</span><span class="fpage" tagx="fpage" title="fpage">202</span><span class="lpage" tagx="lpage" title="lpage">207</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.mimet.2010.11.013">10.1016/j.mimet.2010.11.013</a></span></span></li> <li tag="ref"><a name="CR15" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Singh</span><span class="given-names" tagx="given-names" title="given-names">R</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nawale</span><span class="given-names" tagx="given-names" title="given-names">LU</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Arkile</span><span class="given-names" tagx="given-names" title="given-names">M</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Chemical and biological metal nanoparticles as antimycobacterial agents: a comparative study</span><span class="source" tagx="source" title="source">Int J Antimicrob Agent</span><span class="year" tagx="year" title="year">2015</span><span class="volume" tagx="volume" title="volume">46</span><span class="fpage" tagx="fpage" title="fpage">183</span><span class="lpage" tagx="lpage" title="lpage">188</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.ijantimicag.2015.03.014">10.1016/j.ijantimicag.2015.03.014</a></span></span></li> <li tag="ref"><a name="CR16" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sturm</span><span class="given-names" tagx="given-names" title="given-names">M</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bertsch</span><span class="given-names" tagx="given-names" title="given-names">A</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">GrÃ¶pl</span><span class="given-names" tagx="given-names" title="given-names">C</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">OpenMSâ€"an open-source software framework for mass spectrometry</span><span class="source" tagx="source" title="source">BMC Bioinformat</span><span class="year" tagx="year" title="year">2008</span><span class="volume" tagx="volume" title="volume">9</span><span class="fpage" tagx="fpage" title="fpage">163</span><span class="pub-id"><a href="https://dx.doi.org/10.1186/1471-2105-9-163">10.1186/1471-2105-9-163</a></span></span></li> <li tag="ref"><a name="CR17" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tatipamula</span><span class="given-names" tagx="given-names" title="given-names">VB</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vedula</span><span class="given-names" tagx="given-names" title="given-names">GS</span></span></span><span class="mixed-article-title" title="mixed-article-title">In vitro anti-inflammatory and cytotoxicity studies of two mangrove associated lichens, Dirinaria consimilis and Ramalina leiodea extracts</span><span class="source" tagx="source" title="source">Hygeia J drugs Med</span><span class="year" tagx="year" title="year">2018</span><span class="volume" tagx="volume" title="volume">10</span><span class="fpage" tagx="fpage" title="fpage">16</span><span class="lpage" tagx="lpage" title="lpage">26</span><span class="pub-id"><a href="https://dx.doi.org/10.15254/H.J.D.Med.10.2018.174">10.15254/H.J.D.Med.10.2018.174</a></span></span></li> <li tag="ref"><a name="CR18" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tatipamula</span><span class="given-names" tagx="given-names" title="given-names">VB</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vedula</span><span class="given-names" tagx="given-names" title="given-names">GS</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sastry</span><span class="given-names" tagx="given-names" title="given-names">AVS</span></span></span><span class="mixed-article-title" title="mixed-article-title">Antarvedisides A-B from manglicolous lichen Dirinaria consimilis (Stirton) and their pharmacological profile</span><span class="source" tagx="source" title="source">Asian J Chem</span><span class="year" tagx="year" title="year">2019</span><span class="volume" tagx="volume" title="volume">31</span><span class="fpage" tagx="fpage" title="fpage">805</span><span class="lpage" tagx="lpage" title="lpage">812</span><span class="pub-id"><a href="https://dx.doi.org/10.14233/ajchem.2019.21734">10.14233/ajchem.2019.21734</a></span></span></li> <li tag="ref"><a name="CR19" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tatipamula</span><span class="given-names" tagx="given-names" title="given-names">VB</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Annam</span><span class="given-names" tagx="given-names" title="given-names">SSP</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nguyen</span><span class="given-names" tagx="given-names" title="given-names">HT</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Sekikaic acid modulates pancreatic Î²-cells in streptozotocin-induced type 2 diabetic rats by inhibiting digestive enzymes</span><span class="source" tagx="source" title="source">Nat Prod Res</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1080/14786419.2020.1775226">10.1080/14786419.2020.1775226</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32498563">32498563</a></span></span></li> </ul> </div> </div>  </body></html>